Form 4: Intuitive Surgical SVP Mark Brosius Executes Stock Sales Under 10b5-1 Trading Plan

Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, sold a total of 66 shares of common stock between May 12 and May 14, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Mark Brosius, a Senior Vice President at Intuitive Surgical, executed multiple sales of Intuitive Surgical common stock.
• The sales occurred on May 12, 13, and 14 of 2025.
• A total of 66 shares were sold across the three days.
• The sales were conducted under a pre-arranged trading plan that complies with SEC Rule 10b5-1.
• The trading plan is set to expire on June 13, 2025.
• The prices per share ranged from $551.97 to $563.
• Following these transactions, Mr. Brosius directly owns 2,025 shares of Intuitive Surgical stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-existing trading plan. There is no indication of positive or negative implications for the company's performance.

Industry Context

Executive stock sales are a common occurrence, and sales under 10b5-1 plans are generally viewed as less impactful since they are pre-arranged. The market reaction to this news is likely to be minimal, as the amount of shares sold is not significant relative to the company's overall market capitalization and trading volume.

Key Dates

Keywords

Form 4, Intuitive Surgical, ISRG, Mark Brosius, Stock Sale, 10b5-1 Trading Plan, SEC, SVP, Chief Manufacturing and Supply Chain